Bio Pharma Dive

APRIL 22, 2024

The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.

Manufacturing 281

Manufacturing Medicine Drugs 281

Pharmaceutical Technology

OCTOBER 3, 2024

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.

Manufacturing 130

Manufacturing Medicine Production Trials 130

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Manufacturing 96

Manufacturing Development Drugs Compliance 96

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. But there are many challenges it will face along the way, such as how to manufacture these drugs in a reproducible, scalable, cost-effective, and safe way for patients. Securing the supply chain.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

Pharmaceutical Technology

FEBRUARY 27, 2025

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

Manufacturing 165

Manufacturing Medicine Production 165

Pharmaceutical Technology

NOVEMBER 29, 2024

Automated Industrial Robotics have delivered a bespoke Just in Time PACE system to CPI’s new Medicines Manufacturing Innovation Centre.

Manufacturing 130

Manufacturing Medicine Clinical Trials Clinical Trials 130

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports.

Manufacturing 111

Manufacturing Medicine Life Science Production 111

Bio Pharma Dive

JULY 11, 2022

Gavin Newsom announced a $100 million budget to create a production facility and to develop affordable insulin products, saying the medicines’ high cost “epitomizes market failures.”

Insulin 240

Insulin Manufacturing Production Medicine 240

Bio Pharma Dive

MAY 2, 2022

The regulator cited concerns around single-country trials in turning back Hutchmed's pancreatic cancer treatment, while manufacturing issues held up Junshi and Coherus' throat cancer medicine.

Development 327

Development Regulation Manufacturing Drugs 327

Bio Pharma Dive

JANUARY 6, 2022

Merck KGaA is buying Indianapolis-based Exelead, a specialist in the lipid nanoparticles used to ferry mRNA into the body, for $780 million in cash.

Medicine 164

Medicine Manufacturing 164

Pharmaceutical Technology

OCTOBER 4, 2024

in funding for expanding critical medicine components manufacturing. National Resilience’s subsidiary Resilience Government Services has received around $17.5m

Medicine 130

Medicine Production Manufacturing 130

Pharma Times

OCTOBER 17, 2024

The two-year programme will use virtual reality technology to teach essential skills

Manufacturing 136

Manufacturing Medicine Life Science 136

Bio Pharma Dive

APRIL 2, 2025

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.

Genetics 143

Genetics Medicine Gene Manufacturing 143

Bio Pharma Dive

AUGUST 5, 2024

For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.

Branding 260

Branding Manufacturing Medicine Marketing 260

Pharmaceutical Technology

APRIL 18, 2023

Eli Lilly and Company (Lilly) has unveiled plans to invest $1.6bn in its two new manufacturing facilities located within the LEAP Innovation Park in Boone County, Indiana, US. The investment at the LEAP site marks the company’s biggest manufacturing investment at a single location to date.

Manufacturing 130

Manufacturing Medicine Genetics Production 130

Drug Patent Watch

JANUARY 23, 2025

With the rise of affordable healthcare initiatives and growing demand for quality medicines, emerging markets present a significant opportunity for generic drug manufacturers to expand their reach and improve access to life-saving treatments. However, generic drug development in emerging markets also presents several challenges.

Generic Drugs 85

Generic Drugs Marketing Development Drugs 85

Pharmaceutical Technology

FEBRUARY 23, 2023

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme.

Vaccination 289

Vaccination Vaccine Gene Therapy Manufacturing 289

Bio Pharma Dive

DECEMBER 16, 2021

The new facility cost nearly $70 million to build, and is part of a major push by the pharma giant to become a leader in genetic medicine manufacturing.

Gene Therapy 241

Gene Therapy Gene Genetics Manufacturing 241

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 8, 2024

Last week, the Australian Therapeutic Goods Administration added intravenous (IV) fluids to the growing list of medicines in short supply. The shortage is due to higher-than-expected demand and manufacturing issues. Two particular IV fluids are affected: saline and compound sodium lactate (also called Hartmann’s solution).

Manufacturing 246

Manufacturing Medicine Clinical Trials Clinical Trials 246

Pharmaceutical Technology

JULY 17, 2024

Upperton Pharma has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its facility in Nottingham.

Manufacturing 147

Manufacturing Medicine Production 147

Pharma Mirror

AUGUST 30, 2022

Cytocentric cell manufacturing keeps the critical cell process parameters of temperature, CO2, and O2 at optimum physiologic levels over the entire production process, not just during incubation steps. The post Testing Facility Called “Game Changer” in Regenerative Medicine appeared first on Pharma Mirror Magazine.

Medicine 130

Medicine In-Vitro Manufacturing Production 130

Pharmaceutical Technology

FEBRUARY 8, 2023

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of Genenta Science.

Manufacturing 130

Manufacturing Gene Therapy Production Clinical Trials 130

Pharmaceutical Technology

DECEMBER 15, 2022

On November 16, 2022, Medicines for Europe (MFE), the generics and biosimilars body, called for EU and national reforms to improve the security of medicine supplies, including tackling the impact of inflation on the security of essential medicine supplies with smart procurement guidelines for medicine.

Medicine 246

Medicine Manufacturing Pharma Companies Production 246

pharmaphorum

NOVEMBER 21, 2024

Explore how investing in genomic medicine can unlock the true business potential in the manufacturing and therapeutic areas. Understand the promise and reality of this cutting-edge field.

Genome 111

Genome Genomics Medicine Manufacturing 111

Pharma Mirror

APRIL 18, 2023

Dudley, UK, April 18th 2023: Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced that it has been granted a Manufacturer’s Authorisation for Investigational Medicinal Products from the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).

Licensing 130

Licensing Licensing Manufacturing Antibody 130

STAT News

APRIL 4, 2023

For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain.

Branding 140

Branding Medicine Manufacturing Drugs 140

STAT News

MARCH 15, 2023

Pfizer had the most drugs on the list of any manufacturer, with five. WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate of inflation on 27 medications administered in physicians’ offices, the agency said Wednesday.

Manufacturing 105

Manufacturing Medicine Drugs 105

Bio Pharma Dive

FEBRUARY 6, 2024

The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.

Drug Delivery 210

Drug Delivery Life Science Gene Manufacturing 210

pharmaphorum

MARCH 15, 2024

Consortium led by Birmingham University unveils a centre of excellence for medicines manufacturing training using VR, to answer a UK skills shortage.

Medicine 114

Medicine Manufacturing 114

Pharmaceutical Technology

APRIL 25, 2023

Forge Biologics has received a qualified person (QP) declaration to manufacture adeno-associated virus (AAV) gene therapies to support European clinical programmes. The company stated that a European QP has completed an in-depth audit at its manufacturing facility in Columbus, Ohio, US.

Gene Therapy 130

Gene Therapy Gene Manufacturing Production 130

Bio Pharma Dive

APRIL 14, 2023

The drugmaker said it is working with the FDA to resolve the issues so it can launch the medicine, an ulcerative colitis treatment known as mirikizumab, “as soon as possible.”

Manufacturing 164

Manufacturing Medicine Drugs 164

Fierce Pharma

NOVEMBER 29, 2023

Seeking to identify ways to improve the discovery and production of medicines, Amgen is expanding its partnership with tech giant Amazon.

Manufacturing 124

Manufacturing Medicine Drugs Production 124

pharmaphorum

APRIL 11, 2025

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there

Manufacturing 83

Manufacturing Medicine 83

Pharmaceutical Technology

APRIL 14, 2023

The US Food and Drug Administration (FDA) has rejected Eli Lilly’s biologic licence application (BLA) for the ulcerative colitis (UC) drug mirikizumab over manufacturing concerns. No concerns related to the clinical data package, safety or the medicine label. The regulator has issued a complete response letter.

Manufacturing 130

Manufacturing Drugs Hormones Packaging 130

XTalks

OCTOBER 22, 2024

Canadian contract development and manufacturing organization (CDMO) OmniaBio has debuted its new state-of-the-art facility focused on cell and gene therapy (CGT) manufacturing. Focused on advancing regenerative medicine, CCRM supports the development of cell and gene therapies, along with the associated enabling technologies.

Gene Therapy 105

Gene Therapy Manufacturing Gene Life Science 105

Bio Pharma Dive

OCTOBER 2, 2024

With its latest investment, Lilly is looking toward medicines of the future and new methods to produce them.

Manufacturing 130

Manufacturing Medicine Drugs 130

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. In April 2023, Forge Biologics received a qualified person (QP) declaration for the manufacture of AAV gene therapies at its facility in Columbus, Ohio, US.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256